“Dermatologic immune-related adverse events with immune checkpoint inhibitors”, Can Dermatol Today, vol. 3, no. 3, pp. 40–46, Sep. 2022, Accessed: Mar. 19, 2026. [Online]. Available: https://canadiandermatologytoday.com/article/view/3-3-jfri